Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics. (Q36929181)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Richard Holt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Woodie M Zachry

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jerry D Clewell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Paul A Orth

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jamie L Karagianis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Vicki Poole Hoffmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

4 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

Annals of Pharmacotherapy

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1593-1603

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

Effects of newer antipsychotics on extrapyramidal function

5 January 2020

cites work

1 reference

Physical health monitoring of patients with schizophrenia

21 January 2018

1 reference

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

21 January 2018

1 reference

Consensus development conference on antipsychotic drugs and obesity and diabetes

21 January 2018

1 reference

Pharmacoepidemiology II: the nested case-control study--a novel approach in pharmacoepidemiologic research

21 January 2018

1 reference

Pharmacoepidemiology I: a review of pharmacoepidemiologic study designs

21 January 2018

1 reference

Frequency of new-onset diabetes mellitus and use of antipsychotic drugs among Central Texas veterans

21 January 2018

1 reference

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

21 January 2018

1 reference

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study

21 January 2018

1 reference

Incidence of diabetes in a general practice population: a database cohort study on the relationship with haloperidol, olanzapine, risperidone or quetiapine exposure

21 January 2018

1 reference

Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population

21 January 2018

1 reference

Exploring the risk of diabetes mellitus and dyslipidemia among ambulatory users of atypical antipsychotics: a population-based comparison of risperidone and olanzapine

21 January 2018

1 reference

Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults

21 January 2018

1 reference

Weight gain and new onset diabetes associated with olanzapine and risperidone

21 January 2018

1 reference

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine

21 January 2018

1 reference

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders

21 January 2018

1 reference

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

21 January 2018

1 reference

Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach

21 January 2018

1 reference

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

21 January 2018

1 reference

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients

21 January 2018

1 reference

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims

21 January 2018

1 reference

Clozapine use and risk of diabetes mellitus

21 January 2018

1 reference

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

21 January 2018

1 reference

Relationship of atypical antipsychotics with development of diabetes mellitus

21 January 2018

1 reference

Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects

21 January 2018

1 reference

Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study

21 January 2018

1 reference

Weight gain as a risk factor for clinical diabetes mellitus in women.

21 January 2018

1 reference

Changes in incidence of diabetes in U.S. adults, 1997-2003.

21 January 2018

1 reference

Lifetime Risk for Diabetes Mellitus in the United States

21 January 2018

1 reference

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?

21 January 2018

1 reference

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

21 January 2018

1 reference

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

21 January 2018

1 reference

Clozapine-associated diabetes

21 January 2018

1 reference

Olanzapine-associated diabetes mellitus

21 January 2018

1 reference

Risperidone-associated diabetes mellitus: a pharmacovigilance study

21 January 2018

1 reference

Glucose intolerance with atypical antipsychotics

21 January 2018

1 reference

Glucocorticoids and the risk for initiation of hypoglycemic therapy.

21 January 2018

1 reference

Beta-adrenoceptor-blocking drugs and blood sugar control in diabetes mellitus

21 January 2018

1 reference

Incidence, prevalence, and surveillance for diabetes in New York State psychiatric hospitals, 1997-2004.

21 January 2018

1 reference

Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells.

21 January 2018

1 reference

The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients.

21 January 2018

1 reference

Incident Diabetes Associated With Antipsychotic Use in the United Kingdom General Practice Research Debate

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1K141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17785613%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference